1. Home
  2. GGR vs NRXS Comparison

GGR vs NRXS Comparison

Compare GGR & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogoro Inc.

GGR

Gogoro Inc.

HOLD

Current Price

$3.05

Market Cap

47.7M

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$5.00

Market Cap

46.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGR
NRXS
Founded
2011
2011
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
46.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GGR
NRXS
Price
$3.05
$5.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
10.9K
76.1K
Earning Date
02-12-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$280,211,000.00
$3,362,320.00
Revenue This Year
N/A
$31.05
Revenue Next Year
$6.15
$137.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.89
52 Week Low
$2.72
$1.33
52 Week High
$10.00
$6.20

Technical Indicators

Market Signals
Indicator
GGR
NRXS
Relative Strength Index (RSI) 44.61 52.18
Support Level $2.82 $4.50
Resistance Level $3.14 $5.14
Average True Range (ATR) 0.13 0.32
MACD 0.00 -0.03
Stochastic Oscillator 36.78 37.99

Price Performance

Historical Comparison
GGR
NRXS

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: